CRISPR Therapeutics AG (CRSP) IPO Opens Up 7%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
CRISPR Therapeutics (CRSP) Prices 4M Common Stock IPO at $14/Share, Below Prior Expectations
October 19, 2016 6:15 AM EDTCRISPR Therapeutics AG (Nasdaq: CRSP) announced the pricing of its initial public offering of 4,000,000 common shares at a public offering price of $14.00 per share. In addition, CRISPR Therapeutics has granted the underwriters a 30-day option to purchase up to 600,000 additional common shares at the initial public offering price, less the underwriting discounts and commissions. CRISPR Therapeutics common shares are expected to begin trading on the NASDAQ Global Market under the ticker symbol CRSP on October 19, 2016. The offering is expected to close on October 24, 2016, subject to customary closing conditions.
(*** Note: The company... More
